Raj Makkar, MD, Cedars-Sinai, explains the late-breaking data from the Align-AR trial on the first 500 patients treated for aortic regurgitation using the Jena Valve TAVR device.
The late-breaking five-year results of the Evolut Low-Risk Trial presented at the American College of Cardiology (ACC) 2025 meeting in late March, showed positive results for the Evolut transcatheter aortic valve replacement (TAVR) system vs. surgical aortic valve replacement (SAVR).
Eating a potassium-rich diet can help women lower their blood pressure and reduce their risk of cardiovascular events by a significant margin, according to a new study of more than 25,000 adults.
During valve-in-valve TMVR, patients are treated with conscious sedation or monitored anesthesia care instead of general anesthesia. This new analysis confirms that the change does not impact patient outcomes, but it was linked to a shorter length of stay.
A new trial for participants from 16 church groups in Minnesota showed that app users significantly improved their heart health scores after just 10 weeks.
Limiting salt is a common recommendation for patients hoping to improve their heart health or lose weight. According to a new analysis of more than 1,700 patients, however, going too far with such restrictions can lead to worse outcomes.
The study's authors explored data from 35 patients who received the TricValve Transcatheter Bicaval Valves System. All patients presented with severe tricuspid regurgitation.
Focused rotary jet spinning appears to hold some key advantages over 3D printing and other techniques. Engineers at Harvard think it could represent the future of organ biofabrication.
